Egfr Inhibitor Induced Folliculitis clinical trials

Explore recruiting egfr inhibitor induced folliculitis clinical trials.

Recruiting egfr inhibitor induced folliculitis studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Egfr Inhibitor Induced Folliculitis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A phase 2a multicentric study of TAR-0520 gel in EGFR inhibitor-induced folliculitis

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Egfr Inhibitor Induced Folliculitis trials by city

Egfr Inhibitor Induced Folliculitis in Toronto Egfr Inhibitor Induced Folliculitis in Vancouver Egfr Inhibitor Induced Folliculitis in Montreal Egfr Inhibitor Induced Folliculitis in Calgary Egfr Inhibitor Induced Folliculitis in Edmonton Egfr Inhibitor Induced Folliculitis in Ottawa Egfr Inhibitor Induced Folliculitis in Winnipeg Egfr Inhibitor Induced Folliculitis in Quebec City Egfr Inhibitor Induced Folliculitis in Hamilton Egfr Inhibitor Induced Folliculitis in Kitchener Egfr Inhibitor Induced Folliculitis in London Egfr Inhibitor Induced Folliculitis in Halifax Egfr Inhibitor Induced Folliculitis in New York Egfr Inhibitor Induced Folliculitis in Los Angeles Egfr Inhibitor Induced Folliculitis in Chicago Egfr Inhibitor Induced Folliculitis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease